Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories has initiated voluntarily recall of over half a million Famotidine tablets bottles from the US market as the drug failed impurities or degradation specifications. As many as 5,69,376 bottles of Famotidine tablets, 10 mg belonging to multiple lots packaged in 30-count, are being recalled nationwide. The drug is an over-the-counter (OTC) product used to treat and prevent ulcers in stomach and intestines.

According to a notification put up by the US Food and Drug Administration, the recall is being made under ‘Class-III’ classification, which is described as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.